Larry is a Senior Lecturer at Harvard Business School, focusing on leadership, strategy and general management in the MBA and executive education programs. He recently joined Bain Capital Private Equity as a Senior Advisor.
Larry Culp served as the Chief Executive officer and President of Danaher Corporation from 2000 to 2014, during which time the company increased revenues and its market capitalization five-fold to $20 billion and $50 billion, respectively. Investors and analysts alike consistently ranked him as one of the top CEO’s in annual Institutional Investor surveys. Harvard Business Review named Mr. Culp one of the Top 50 CEO’s in the world.
Under his leadership, Danaher expanded international sales from 40 percent to 60 percent, and deployed nearly $25 billion for strategic acquisitions. Larry was instrumental in the establishment and growth of their health care, environmental, product identification and test and measurement platforms and in the evolution of the Danaher Business System, the common operating philosophy and model deployed company-wide.
Larry joined Danaher in 1990 at Veeder-Root, becoming president in 1993. He was appointed Group Executive and Corporate Officer in 1995, with responsibility for Danaher’s Environmental and Electronic Test and Measurement platforms. During this time, he also served as President of Fluke and Fluke Networks. In 1999, he became Executive Vice President, in 2001 Chief Operating officer, and in 2001 President and CEO.
Mr. Culp is a member of the T. Rowe Price Group Board of Directors, chairs the Board of Visitors and Governors of his alma mater, Washington College, and is a member of the Wake Forest Board of Trustees. Previously, Larry served on the board of GlaxoSmithKline and chaired the board of the Potomac School.
A member of Phi Beta Kappa, Larry received a B.A in Economics from Washington College and an MBA from Harvard Business School.